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INTRODUCTION 
 
                          The International Association of Study of Pain defines 
Pain as ‘ an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage or described in terms of such damage ’ 
Patients often perceive postoperative pain as the most ominous part of 
undergoing a surgical procedure. In the past treatment of postoperative 
pain was given low priority by care givers and pain was considered a 
requisite part of  the comprehensive postoperative experience  
                                    But with the improvement in the knowledge of the 
epidemiology and pathophysiology of pain, more attention has now been 
focused on the management of post-operative pain in an effort to improve 
quality of care and patient outcome. 
Post thyroidectomy pain is attributed to the cervicotomy, intraoperative 
extension of neck, larygeal irritation caused by endo-tracheal tube and 
pain due to wound drains. This pain is usually treated with opioids and 
NSAIDS. But opioids are associated with many side effects like nausea 
and vomiting. Multimodal analgesic methods have come into vogue to 
reduce the side effects  and to improve post-operative analgesia . 
                                    Also as evidence continues to accumulate 
concerning the role of central sensitization in postoperative pain, many 
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researchers have focused on methods to prevent central neuroplastic 
changes from occurring through the utilization of preemptive analgesic 
techniques. Effective preventative analgesic techniques may not only be 
useful in reducing acute pain but also chronic post-surgical pain and 
disability.Pre-emptive analgesic techniques described for thyroidectomies 
are wound infiltration with local anaesthetics, bilateral superficial plexus 
blocks, cervical epidural , pre-emptive administration of NSAIDS, 
anticonvulsants like Gabapentin and Pregabalin 1, 2. 
                                  Anticonvulsants are widely used to treat the 
allodynia and hyperalgesia associated with neuropathic pain. But they 
were not thought to be useful in inflammatory or post-operative pain. 
However accumulating laboratory and clinical evidence, including post 
operative analgesic trials suggests that gabapentin and its analogues such 
as Pregabalin are analgesics across a wide spectrum of pain states. This 
could be attributed to certain neural changes, common both to 
neuropathic and post tissue injury pain.  
                                  Recent studies have explored Gabapentin’s role in 
post-operative pain relief. The objective of the present study was to 
examine the post-operative analgesic effectiveness, opioid sparing effect 
and side effects of  pre-emptive  Gabapentin in patients undergoing 
thyroid surgeries. 
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AIM 
 
                              The aim of the present study was to examine the 
analgesic effectiveness, opioid-sparing effects and side effects associated 
with pre-emptive administration of gabapentin in patients undergoing 
thyroid surgeries. 
 
 
 
 
 
 
 
 
 
9  
 
 
REVIEW OF LITERATURE 
 
1) Mark J. Field, Elizabeth F. Holloman et al studied the effect of 
Gabapentin and S-(+)-3-Isobutylgaba in a Rat Model of Postoperative 
Pain. An incision of the plantaris muscle of a hind paw induced thermal 
hyperalgesia and tactile allodynia lasting at least 3 days. Postoperative 
testing was carried out using the plantar test for thermal hyperalgesia and 
von Frey hairs for tactile allodynia. A single s.c. dose of gabapentin, 1 h 
before surgery, dose-dependently (3-30 mg/kg) blocked the development 
of allodynia and hyperalgesia with a minimum effective dose (MED) of 
10 and 30 mg/kg, respectively. The highest dose of gabapentin prevented 
development of hyperalgesia and allodynia for 24 and 49 h, respectively. 
2) Werner MU, Perkins FM et al studied the effect of gabapentin in acute 
inflammatory pain in humans. Twenty-two volunteers were investigated 
in a double-blind, randomized, placebo-controlled cross-over study. 
Gabapentin 1,200 mg or placebo was given on 2 separate study days. 
Three hours after drug administration, a first-degree burn injury was 
produced on the medial aspect of the nondominant calf . Gabapentin 
diminished the decrease in mechanical pain threshold in the burn area and 
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reduced secondary hyperalgesia. Ratings of drowsiness and unsteadiness 
during walking were significantly higher for gabapentin than for placebo. 
The study indicates that gabapentin has no analgesic effect in normal 
skin, but may reduce primary mechanical allodynia in acute inflammation 
following a thermal injury. These observations suggest a clinical potential 
of gabapentin in the treatment of postoperative pain.  
3) Dirks J. Peterson KL et al tried to link data from animal models and 
clinical trials for chronic pain by investigating the effect of gabapentin on 
acute nociception and experimentally induced cutaneous hyperalgesia in 
healthy volunteers. study showed oral gabapentin profoundly suppressed 
established cutaneous sensitization on the forearm and prevented 
development of cutaneous sensitization on the thigh. Thermal nociception 
in normal skin was unchanged.  
                     Many randomized clinical studies explored the role of 
gabapentin in reducing peri-operative pain . 
4) Turan b,Kumaralingalou et al Investigated the effects of gabapentin on 
acute postoperative pain and morphine consumption in patients 
undergoing spinal surgery. Their study showed that preoperative oral 
gabapentin decreased pain scores in the early postoperative period and 
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postoperative morphine consumption in spinal surgery patients while 
decreasing some morphine-associated side effects. 
5) Dilek Memi , MD*, Pinar Usar, et al investigated, in a randomized, 
placebo-controlled, double-blind study, the efficacy and safety of 
gabapentin on pain after abdominal hysterectomy and on tramadol 
consumption in patients.The VAS scores in the sitting and supine position 
at 1, 4, 8, 12, 16, and 20 hour were significantly lower in the gabapentin 
group when compared with the placebo group up to 20 h after surgery. 
The tramadol consumption at 12, 16, 20, and 24 h and total tramadol 
consumption were significantly less in the gabapentin group when 
compared with placebo group. Sedation scores were similar at all the 
measured times. There were no differences between groups in adverse 
effects. 
6) Turan A, Memis D,24  investigated the efficacy and safety of 
gabapentin in patients who underwent rhinoplasty or endoscopic sinus 
surgery patients under monitored anesthesia care. . Postoperative pain 
scores and intraoperative pain scores at 45 and 60 min were significantly 
lower in the gabapentin group. Fentanyl (122 ± 40 µg versus 148 ± 42 µg; 
P < 0.05) and diclofenac (33 ± 53 mg versus 111 ± 92 mg; P < 0.001) 
consumption was smaller and the time to first analgesic request (18 ± 9 h 
versus 9 ± 7 h; P < 0.001) was longer in the gabapentin group. A more 
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frequent incidence of dizziness was found in the gabapentin (versus 
placebo) group (24% versus 4%, respectively). 
7) Dirks J, Fredensborg BB et al studied the effect of a single dose of 
1,200 mg oral gabapentin versus placebo on postoperative pain and 
morphine consumption after mastectomy result showed a substantial 
reduction in postoperative morphine consumption and movement-related 
pain after radical mastectomy, without significant side effects. 
 8) Chandra Kant Pandey, MD, Shio Priye,et al Four hundred fifty-nine 
ASA I and II patients were randomly assigned to receive 300 mg 
gabapentin, 100 mg tramadol or placebo in a double-blind manner two 
hours before laparoscopic cholecystectomy under general anesthesia.they 
found out that Significantly less fentanyl was consumed in the gabapentin 
group than in the tramadol  and placebo groups. Sedation , 
nausea/retching/vomiting  were the commonest side effects in the 
gabapentin group whereas respiratory depression was the commonest in 
the tramadol group and vertigoin the placebo group 
9) Rorarius MG,Mennander S et al gave 1200 mg of gabapentin or 15 mg 
of oxazepam (active placebo) 2.5 h prior to induction of anaesthesia to 
patients undergoing elective vaginal hysterectomy in an active placebo-
controlled, double blind, randomised study. they found that  Gabapentin 
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reduced the need for additional postoperative pain treatment  by 40% 
during the first 20 postoperative hours. During the first 2 postoperative 
hours pain scores at rest and worst pain score (VAS 0-100 mm) were 
significantly higher in the active placebo group compared to the 
gabapentin-treated patients. Additionally, pretreatment with gabapentin 
reduced the degree of postoperative nausea and incidence of vomiting. 
10) Al-Mujadi H, A-Refai AR 19 et al gave gabapentin 1200 mg or 
placebo two hours prior to induction of anesthesia to patients undergoing 
elective thyroidectomy. They found that overall, pain scores at rest and 
during swallowing in the gabapentin group were significantly lower when 
compared with the placebo group. No significant differences in side 
effects were observed between groups.  
11) Pandey CK, Navkar DV,et al evaluated the optimal preemptive dose 
of gabapentin for postoperative pain relief after single-level lumbar 
diskectomy and its effect on fentanyl consumption during the initial 24 
hours. Patients were divided into five groups to receive placebo or 
gabapentin 300, 600, 900, or 1200 mg 2 hours before surgery. ).they 
found that Patients who received gabapentin 600, 900, and 1200 mg had 
lower VAS scores at all time points than patients who received 
gabapentin 300 mg (P < 0.05). Increasing the dose of gabapentin from 
600 to 1200 mg did not decrease the VAS score, nor did the increasing 
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dose of gabapentin significantly decrease fentanyl consumption. Thus, 
gabapentin 600 mg is the optimal dose for postoperative pain relief. 
12)Klaus Eckhardt, MD, Susanne Ammon, MD, et al investigated, in a 
randomized, placebo-controlled, double-blinded study, the 
pharmacodynamic and pharmacokinetic interaction of GBP and morphine 
in 12 healthy male volunteers. Morphine (60 mg, controlled release) or 
placebo was administered at 8:00 AM, and GBP (600 mg) or placebo was 
administered at 10:00 AM, thus comparing the analgesic effect of placebo 
+ GBP (600 mg) with placebo + placebo and morphine (60 mg) + GBP in 
comparison to morphine plus placebo by using the cold pressor test.The 
results showed that gabapentin enhanced the acute analgesic effect of 
morphine. Furthermore, the plasma concentration of gabapentin was 
increased when morphine was administered concomitantly. 
                   There were some metanalysis and review articles which 
analyzed the various studies of gabapentin as a pre emptive analgesic. 
13) Seib RK,Paul JE et al Conducted a metaanalysis to find out whether 
gabapentin reduces pain scores, analgesia consumption, and/or analgesia-
related side effects in the first 24 hr following surgery. they conclude that 
Although gabapentin given preoperatively decreases pain scores and 
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analgesic consumption in the first 24 hr after surgery, the clinical 
significance of this finding has yet to be determined. 
.  
14) Ho KY, Gan TJ, Habib AS. Did a systematic review of randomized 
controlled trials. When gabapentin was administered at doses less than 
1200 mg, pain intensity was also lower at 6 h (WMD, -22.43 mm) and 24 
h (WMD, -13.18 mm). Cumulative 24 h opioid consumption was also 
lower (WMD, -7.25 mg). Gabapentin was associated with an increased 
risk of sedation (Peto OR 3.86; 95% CI 2.50-5.94) but less opioid-related 
side effects such as vomiting (Peto OR 0.58; 95% CI 0.39-0.86) and 
pruritus (Peto OR 0.27; 95% CI 0.10-0.74). In conclusion, gabapentin has 
an analgesic and opioid-sparing effect in acute postoperative pain 
management when used in conjunction with opioids. 
METHODS: Sixty patients scheduled for abdominal hysterectomy were 
randomized to receive orally gabapentin 400 mg 6 hourly or placebo. 
Treatment started 18 h preoperatively and continued for 5 postoperative 
days. Pain (visual analogue score) and consumption of morphine for 48 h 
and of oral paracetamol/codeine were recorded after 2, 4, 8, 24 and 48 h 
and on days 3-5 postoperatively. After 1 month, patients were 
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interviewed by phone for pain, and analgesic intake after hospital 
discharge 
15)Mathiesen O, Møiniche S, Dahl JB.did a qualitative and quantitative 
systematic review, with focus on procedure of Gabapentin and 
postoperative pain: Twenty-three trials with 1529 patients were included. 
In 12 of 16 studies with data on postoperative opioid requirement, the 
reported 24-hour opioid consumption was significantly reduced with 
gabapentin. Quantitative analysis of five trials in abdominal hysterectomy 
showed a significant reduction in morphine consumption (WMD - 13 mg, 
95% confidence interval (CI) -19 to -8 mg), and in early pain scores at 
rest (WMD - 11 mm on the VAS, 95% CI -12 to -2 mm) and during 
activity (WMD -8 mm on the VAS; 95% CI -13 to -3 mm), favouring 
gabapentin. In spinal surgery, (4 trials), analyses demonstrated a 
significant reduction in morphine consumption (WMD of - 31 mg 
(95%CI - 53 to -10 mg) and pain scores, early (WMD - 17 mm on the 
VAS; 95 % CI -31 to -3 mm) and late (WMD -12 mm on the VAS; 95% 
CI -23 to -1 mm) also favouring gabapentin treatment. Nausea was 
reduced with gabapentin in abdominal hysterectomy (RR 0.7; 95 % CI 
0.5 to 0.9). Other side-effects were unaffected 
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. 
16)Tiippana EM, Hamunen K, Kontinen VK, also E.did a A systematic 
review of efficacy and safety to find if surgical patients benefit from 
perioperative gabapentin/pregabalin. They found that Pain relief was 
better in the gabapentin groups compared with the control groups. The 
opioid-sparing effect during the first 24 h after a single dose of 
gabapentin 300-1200 mg, administered 1-2 h preoperatively, ranged from 
20% to 62%. The combined effect of a single dose of gabapentin was a 
reduction of opioid consumption equivalent to 30 +/- 4 mg of morphine 
(mean +/- 95% CI) during the first 24 h after surgery. Metaregression 
analysis suggested that the gabapentin-induced reduction in the 24-h 
opioid consumption was not significantly dependent on the gabapentin 
dose. Gabapentin reduced opioid-related adverse effects, such as nausea, 
vomiting, and urinary retention (number-needed-to-treat 25, 6, and 7, 
respectively). The most common adverse effects of the gabapentinoids 
were sedation and dizziness (number-needed-to-harm 35 and 12, 
respectively 
17)Gilron I. Can J Anaesth. 2006 Jun;53(6):562-71reviewed preclinical 
evidence and clinical trial data describing the efficacy and safety of 
anticonvulsant drugs in the setting of postoperative pain management. He 
suggested that anticonvulsant drugs may alleviate postoperative anxiety, 
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accelerate postoperative functional recovery and reduce chronic 
postsurgical pain. 
18) Wiffen PJ, McQuay HJ et al.did a Cochrane data review to evaluate the 
analgesic effectiveness and adverse effects of gabapentin for pain 
management in clinical practice. SEARCH STRATEGY: Randomised 
trials of gabapentin in acute, chronic or cancer pain were identified by 
MEDLINE (1966-Nov 2004), Data were extracted by two independent 
reviewers, and trials were quality scored. Numbers-needed-to-treat 
(NNTs) were calculated, where possible, from dichotomous data for 
effectiveness, adverse effects and drug-related study withdrawal. 
Fourteen reports describing 15 studies of gabapentin were considered 
eligible (1468 participants)The study in acute post-operative pain (70 
participants) showed no benefit for gabapentin compared to placebo for 
pain at rest.In chronic pain, the NNT for improvement in all trials with 
evaluable data is 4.3 (95%CI 3.5-5.7). Forty two percent of participants 
improved on gabapentin compared to 19% on placebo. The number 
needed to harm(NNH) for adverse events leading to withdrawal from a 
trial was not significant. Fourteen percent of participants withdrew from 
active arms compared to 10% in placebo arms. The NNH for minor harm 
was 3.7 (95% CI 2.4 to 5.4). The NNT for effective pain relief in diabetic 
neuropathy was 2.9 (95% CI 2.2 to 4.3) and for post herpetic neuralgia 
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3.9 (95% CI 3 to 5.7). They concluded that there is evidence to show that 
gabapentin is effective in neuropathic pain. There is limited evidence to 
show that gabapentin is ineffective in acute pain. 
 
 
  
 
 
 
 
 
PHARMACOLOGY OF GABAPENTIN 
 
                                         Gabapentin was introduced for the treatment of 
epilepsy in the early 1990s. Several years later, anecdotal reports 
describing the efficacy of gabapentin for the treatment of neuropathic pain 
began to appear and off-label prescribing for this indication became 
widespread. Large placebo-controlled, double-blind trials confirmed these 
reports and gabapentin became licensed in many countries for the 
treatment of neuropathic pain. 
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STRUCTURE OF GABAPENTIN 
 
               Gabapentin is described as 1-(aminomethyl)cyclohexaneacetic 
acid with a molecular formula of C9H17NO2 and a molecular weight of 
171.24. The structural formula of gabapentin is:    
                Gabapentin is a white to off-white crystalline solid with a pKa1 
of 3.7 and a pKa2 of 10.7. It is freely soluble in water and both basic and 
acidic aqueous solutions. The log of the partition coefficient (n-
octanol/0.05M phosphate buffer) at pH 7.4 is –1.25 
Pharmacokinetics and Drug Metabolism 
 
All pharmacological actions following gabapentin administration are due 
to the activity of the parent compound; gabapentin is not appreciably 
metabolized in humans. 
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Oral Bioavailability: 
                                          Gabapentin bioavailability is not dose 
proportional; i.e., as dose is increased, bioavailability decreases. 
Bioavailability of gabapentin is approximately 50% following 600mg 
oral. Food has only a slight effect on the rate and extent of absorption of 
gabapentin (14% increase in AUC and Cmax). 
 
                                               Distribution: 
             Less than 3% of gabapentin circulates bound to plasma protein. 
The apparent volume of distribution of gabapentin after 150 mg 
intravenous administration is 58±6 L (Mean ±SD). 
Elimination: 
                  Gabapentin is eliminated from the systemic circulation by 
renal excretion as unchanged drug. Gabapentin is not appreciably 
metabolized in humans. 
                  Gabapentin elimination half-life is 5 to 7 hours and is 
unaltered by dose or following multiple dosing. Gabapentin elimination 
rate constant, plasma clearance, and renal clearance are directly 
proportional to creatinine clearance. In elderly patients, and in patients 
with impaired renal function, gabapentin plasma clearance is reduced. 
Gabapentin can be removed from plasma by hemodialysis. 
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Age:   Oral clearance (CL/F) of gabapentin decreased as age increased, 
from about 225 mL/min in those under 30 years of age to about 125 
mL/min in those over 70 years of age. Renal clearance (CLr) also 
declined  with age, which can largely be explained by the age related 
decline in renal function.  
 
Gender: Although no formal study has been conducted to compare the 
pharmacokinetics of gabapentin in men and women,it appears that the 
pharmacokinetic parameters for males and females are similar and there 
are no significant gender differences. 
Race: Pharmacokinetic differences due to race have not been studied. 
Because gabapentin is primarily renally excreted and there are no 
important racial differences in creatinine clearance, pharmacokinetic 
differences due to race are not expected. 
 
ANALGESIC EFFECT  OF GABAPENTIN 
  
                          Despite intensive study, the basis of gabapentin analgesia 
remains uncertain. But in animal models of analgesia, gabapentin 
prevents allodynia (pain-related behavior in response to a normally 
innocuous stimulus) and hyperalgesia (exaggerated response to painful 
23  
stimuli). In particular, gabapentin prevents pain-related responses in 
several models of neuropathic pain in rats or mice (e.g. spinal nerve 
ligation models, streptozocin-induced diabetes model, spinal cord injury 
model, acute herpes zoster infection model). Gabapentin also decreases 
pain-related responses after peripheral inflammation (carrageenan footpad 
test, late phase of formalin test). Gabapentin did not alter immediate pain-
related behaviors (rat tail flick test, formalin footpad acute phase, acetic 
acid abdominal constriction test, footpad heat irradiation test). The 
relevance of these models to human pain is not known.  
                                          Gabapentin was developed as an analogue to 
the neurotransmitter GABA but has since been shown not to interact with 
either GABAa or GABAb receptors. GABA-ergic function could be 
potentiated without direct interaction with GABA receptors by increasing 
the concentration of GABA in neuronal tissue through release of GABA 
from nerve terminals,enzyme effects, or decreased GABA 
breakdown.Another possible mechanism is mobilization of intracellular 
GABA via  gabapentin sensitive transporters.  
                                         However the best evidence comes from studies 
of gabapentin on a specific gabapentin - binding protein found in brain 
and spinal cord. The binding site a2d  ,is a subunit of n-type voltage -
gated calcium channel found in high density in cerebral cortex, 
superficial dorsal horn, cerebellum and hippocampus studies in spinal 
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cord dorsal horn have found that gabapentin binding is primarily post-
synaptic.GABA itself has no activity at this binding site, but gabapentin 
analogues that bind to a2d subunit do appear to have analgesic activity 
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SPINOTHALAMIC TRACT 
 
 
 
 
 
                         Arrangement of pain pathways in spinal cord 
 
26  
 
 
 
 
NEUROANATOMY OF PAIN 
                                               
                              Traditionally there have been two major theories of 
pain sensation. Specificity theory, postulated by Von frey proposes that 
pain as well as other modalities like touch, warmth and cold each has a 
distinctive end organ in the skin and that each ‘stimulus specific’ end 
organ is connected by its own pathway to the brain. A second theory of 
which Gold Schneider was an early protagonist held that any sensory 
stimulus if sufficiently intense could produce pain. According to this 
there are no distinct pain receptors and the sensation of pain is the result 
of the summation of impulses excited by thermal stimuli or pressure 
applied to the skin. Originally called the intensive theory it later came to 
be known as the Pattern or Summation theory. More recent investigations 
have reconciled to these opposing views. 
                          It is now well established that two types of afferent 
fibers, the distal axons of primary afferent neurons, respond maximally to 
noxious stimuli. One type is, the very fine, unmyelinated, so called c fiber 
(0.4-1.1μm in diameter) and the other is the thinly myelinated A delta 
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fiber (1.0-5.0μm in diameter). They terminate peripherally at the free 
nerve endings in the skin and other organs. These free nerve endings are 
fine, profusely branched nerve fibers that are covered by Schwann cells 
and contain little or no ‘myelin’ fibers, respond most effectively to 
noxious stimuli. 
PAIN PATHWAYS 
                  
                          Primary afferent neurons are located in the dorsal root 
ganglia, which lie in the vertebral foramina at each spinal cord level. Pain 
fibers may ascend or descend one or three spinal segments in Lissauer’s 
tract before synapsing with second order neurons in the gray matter of the 
ipsilateral dorsal horn. Central extensions of these nerve cells project via 
the dorsal root ganglia to the dorsal horn of the spinal cord. Spinal cord 
grey matter was divided into 10 lamina by Rexed. The first 6 lamina, 
which make up the dorsal horn receive all the afferent neural, and 
represent the principal site of modulation of pain by ascending and 
descending pathways. Most nociceptive C fibers send collaterals to, or 
terminate on, second order neurons in lamina I , II or V. Nociceptive Ad 
fibers terminate in I,V or X. lamina II is also called Substantia 
Gelatinosa, contains many interneurons and plays a major role in 
modulation of pain. It is also the major site of action of opioids. Lamina 
III and IV receive non-nociceptive sensory input. Cell bodies of pre-
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ganglionic sympathetic fibers are in lamina VII. Lamina VIII and IX 
make up the anterior motor horn. 
   
Spinothalamic tract 
                                                                 The Spinothalamic tract(STT) 
transmits information about temperature and pain, as well as “simple” 
touch (i.e. related to localisation of stimulus) and visceral sensations. It 
mediates the discriminative and arousal-emotional components of these 
sensations by separating out the “fast” (discriminative aspect) and “slow” 
(affective aspect) components of pain into different regions of the tract 
that are transmitted in parallel to the thalamus. Discriminative pain 
reaches the thalamus directly without making connections elsewhere in 
the nervous system, whereas arousal-emotional pain reaches the thalamus 
indirectly via connections with brainstem regions. Slow pain is also 
transmitted by other pathways such as the spinoreticular tract.  
The STT may be divided into the lateral STT and the anterior STT. Pain 
and temperature is transmitted mainly in the lateral STT. The lateral-STT 
transmits the sensations of both fast and slow pain. The anterior STT 
conveys sensations of simple touch (stimulus localisation). The STT 
ascends the entire length of the cord and the brainstem, staying in about 
the same location all the way up. It is here in the brainstem that the 
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different modalities separate out to terminate in different thalamic and 
brainstem nuclei. The fast pain STT axons terminate in the 
ventroposterior nucleus, which comprises the ventral posterolateral 
(VPL) and ventral posteromedial (VPM) and the posterior (PO) nuclei. 
These axons seem to mediate mainly the sense of “simple touch” and 
pain. These sensations are separated within the thalamus: neurons in the 
VPL and VPM do not respond specifically to noxious stimulation, 
whereas cells in the PO receive inputs from both low- and high-threshold 
afferents. These cells are associated with the conscious perception of 
pain. 
                                        The slow pain-STT axons innervate the non-
specific intralaminar nuclei of the thalamus, and the reticular formation in 
the brainstem. These axons form at least part of the forebrain pain 
pathway associated with the affective quality (unpleasantness and fear of 
further injury) of pain and can be dissociated from the discriminative 
quality (the type and nature of the injury itself). The projections to the 
reticular formation may underlie the arousal effects of painful stimuli. 
The arousal itself may activate noradrenergic neurons in the locus 
coeruleus, and thus decrease the upward pain transmission.This may be 
an example of a negative feedback loop in the nervous system. 
       Comparison of central pathways for pain transmission 
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 Direct (fast) Indirect (slow) 
Tract Lateral-STT Lateral-STT 
Origin Lamina I & IV, V Lamina I, IV,V, 
Somatotopic   Yes No 
Body representation  Contralateral Bilateral 
Synapse in reticular No Yes 
Sub-cortical targets None Hypothalamus 
Thalamic nucleus Ventral posterolateral Intra-laminar nuclei 
Cortical location Parietal lobe (SI Cingulate gyrus 
Role Discriminative pain Affective-arousal 
Other functions Temperature  
                                  It has long been known that the STT is an important 
pain pathway because when it is damaged, pain and temperature sense is 
abolished on the contralateral side of the body below the lesion. It has 
been used, as a last resort, by surgeons to relieve intractable cancer pain. 
However, pain is not permanently abolished because of preservation of 
one side of the bilateral indirect pathways. Also, the transmission of 
simple tactile modalities (detection, location) via the anterior STT 
explains why touch sensation is preserved in people with dorsal column 
lesions (although they are unable to discriminate the nature of the 
stimulus. 
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PHYSIOLOGY OF PAIN 
 
 
PHYSIOLOGY OF PAIN 
                             Surgical trauma leads to the release of inflammatory 
mediators at the site of injury, resulting in a reduction in the pain 
threshold at the site of injury (primary hyperalgesia) and in the 
surrounding uninjured tissue (secondary hyperalgesia). Peripheral 
sensitization results from a reduction in the threshold of nociceptor 
afferent terminals secondary to surgical trauma. Central sensitization is an 
activity-dependent increase in the excitability of spinal neurons (spinal 
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wind-up) as a result of persistent exposure to afferent input from 
peripheral neurons. 
                                    Operative procedures produce an initial delivery of 
nociceptive signals  and generate a secondary inflammatory response, 
both of which contribute substantially to postoperative pain. The signals 
have the capacity to initiate prolonged changes in both the peripheral and 
central nervous system that will lead to the amplification and 
prolongation of postoperative pain. Increased peripheral sensitization to 
pain (a reduction in the threshold of nociceptor afferent peripheral 
terminals) is a result of inflammation at the site of surgical trauma 
                              Central sensitization, an activity-dependent increase in 
the excitability of spinal neurons, is a result of persistent exposure to 
nociceptive afferent input from the peripheral neurons in the skin. Taken 
together (incoming pain signals and inflammation), these two processes 
contribute to the postoperative hypersensitivity state (“spinal windup”) 
that is responsible for a decrease in the pain threshold, both at the site of 
injury (primary hyperalgesia) and in the surrounding uninjured tissue 
(secondary hyperalgesia) . This is the mechanism by which pain may be 
prolonged beyond the duration normally expected with an acute insult. 
Prolonged central sensitization has the capacity to lead to permanent 
alterations in the CNS including the death of inhibitory neurons, 
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replacement with new afferent excitatory neurons, and the establishment 
of aberrant excitatory synaptic connections. These alterations result in a 
prolonged state of sensitization resulting in intractable post-surgical pain 
that is unresponsive to many analgesics. 
PRE-EMPTIVE ANALGESIA 
                                              As evidence continues to accumulate 
concerning the role of sensitization in the prolongation of postoperative 
pain, many researchers have focused on methods which not only treat the 
symptoms as they occur, but prevent windup from occurring through the 
utilization of preemptive analgesic techniques. The evidence in support of 
preemptive analgesia has been equivocal with one recent systematic 
review of the literature demonstrating no beneficial effect while a more 
recent review demonstrating an overall benefit of this concept. However, 
the concept of preemptive analgesia has evolved beyond the importance 
of only reducing the nociceptive afferent input brought about by the 
surgical incision. The term preventative analgesia was introduced to 
emphasize the fact that central neuroplasticity is induced by both pre-, 
intra-, and postoperative nociceptive inputs. Thus the goal of preventative 
analgesia is to reduce central sensitization that comes from noxious inputs 
arising throughout the entire perioperative period and not just from those 
occurring during the surgical incision. 
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                                  Preemptive treatment should be directed at the 
periphery, along the sensory axons, and central neurons. This can be 
accomplished with the use of nonsteroidal anti-inflammatory drugs 
(NSAIDs), acetaminophen, local anesthetics, alpha -2 agonists 
(clonidine), anticonvulsants (gabapentin and pregabalin), cryotherapy, 
and opioids, either alone or in combination 
 
PAIN ASSESSMENT METHODS 
  
                        In verbal patients, self-report is the gold standard, and 
external signs of pain or distress (eg, crying, wincing, rocking) are 
secondary. For patients who have difficulty communicating and for 
young children, nonverbal indicators (behavioral and sometimes 
physiologic) may need to be the primary source of information. 
Formal measures include verbal category scales (eg, mild, moderate, 
severe), numeric scales, and the Visual Analog Scale (VAS). For the 
numeric scale, patients are asked to rate their pain from 0 to 10 (0 = no 
pain; 10 = “the worst pain ever”). For the VAS, patients make a hash 
mark representing their degree of pain on an unmarked 10-cm line with 
the left side labeled “no pain” and the right side labeled “unbearable 
pain.” The pain score is distance in mm from the left end of the line. 
Children and patients with limited literacy or known developmental 
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problems may select from images of faces ranging from smiling to 
contorted with pain or from fruits of varying sizes to convey their 
perception of pain severity. 
      
 
 
 
VISUAL ANALOGUE SCALE 
                             
                           Visual analogue scale provides a simple, efficient and 
noninvasive measure of the intensity of pain. It is a 10 cm long scale with 
the two end points labeled ‘no pain’ and ‘worst possible pain’. The 
patient makes a mark on the scale at a point corresponding to the intensity 
of pain he or she presently feels. The distance in cm from the lower end 
of the scale to the mark is the numerical value of pain score. 
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MATERIALS AND METHODS 
  
                                    This study was conducted in patients who 
underwent elective thyroid surgeries at Government General Hospital at 
Madras Medical College. The study was approved by institutional ethics 
committee and informed written consent was obtained from all the 
patients. The study was designed to be randomized, double blind and 
placebo controlled. Adults of either sex of American society of 
Anesthesiologists  physical status –I or II scheduled for elective thyroid 
surgeries were eligible for the study. Excluded were patients of ASA 
physical status -III  or IV ,with known allergy to gabapentin, chronic pain 
or recent intake of  analgesics or corticosteroids, history of drug or 
alcohol abuse or impaired renal or liver function.All patients were 
instructed pre-operatively on the use of Visual Analogue Scale. Patients 
were randomly assigned to receive oral Gabapentin 600 mg or placebo 
capsule 2hours before surgery with the help of a computer generated table 
of random numbers. 
                                      All patients received oral Diazepam 10mg on the 
night before surgery. All of them were also premedicated with fentanyl 2 
μg kg-1  and Glycopyrrolate 0.2 mg. Anesthesia was induced with 
propofol 2mg/kg and succinylcholine 1.5mg/kg was given to aid tracheal 
intubation. General anesthesia was maintained with Isoflurane1% and 
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66% nitrous oxide in oxygen. Isoflurane was adjusted to maintain 
adequate depth of anesthesia. Mechanical ventilation was adjusted to 
maintain normocarbia .Neuromuscular blockade was maintained with 
Vecuronium. Fentanyl 1 μg kg-1  was repeated hourly and titrated to 
intensity of surgical stimulus. Continuous electro-cardiogram and heart 
rate, pulse oximetery, non invasive blood pressure and end tidal carbon 
dioxide were monitored during anesthesia.  At the end of  surgery 
residual neuromuscular blockade was reversed with Neostigmine 
0.04mg/kg iv and Glycopyrrolate 0.4mg iv. After tracheal extubation 
patients were transferred to the post anesthesia care unit (PACU) 
                                        In  PACU a resident doctor who was blinded 
with respect to the treatment group recorded the VAS pain scores at first 
hour following surgery, then at two ,six, 12 , 18 , and 24 hours in the post 
operative period. Fentanyl 1 μg kg-1  was given to the patient by the staff 
nurse as a rescue analgesic at the patients demand or if VAS score is 5 or 
greater. The total fentanyl consumption in 24 hours was recorded. 
Sedation was graded using Ramsay sedation score. Side effects including 
Nausea and vomiting, Respiratory depression, dizziness and diarrhea 
were recorded. Ondansetron 4 mg iv mg iv was used to treat nausea and 
vomiting. A Patient was considered to have respiratory depression if his 
respiratory rate <8 or oxygen saturation was less than 90 %. 
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                RAMSAY  SEDATION SCORE 
1 Anxious ,Agitated or Restless 
2 Cooperative, Oriented and Tranquil 
3 Responds to command 
4 Asleep but has a brisk response to a light glabellar tap 
or loud auditory stimulus 
5 Asleep but has a sluggish response to a light glabellar tap 
or loud auditory stimulus 
6 Asleep, no response 
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OBSERVATION AND RESULTS 
 
                          Eighty consecutive patients who fulfilled the inclusion 
criteria were enrolled in the study. Surgery was postponed for three 
patients in Placebo group and two patients in Gabapentin group. One 
patient in placebo group developed immediate postoperative stridor and 
another patient in gabapentin group had to undergo re-exploration for 
reactionary hemorrhage. Both were excluded from the study. Three 
patients from placebo group and two patients from gabapentin group were 
excluded because they received a different analgesic which was 
prescribed by surgeon. Thus data from 35 patients of gabapentin group 
and 33 patients of placebo group were included and analyzed. 
                                                After completion of study the data was 
unblinded and analyzed using statistical software package SPSS 10. 
Demographic data was analyzed with two sample student’s t-test. 
Fentanyl consumption and VAS scores were analyzed using two way 
ANOVA with drug administered as one factor and the time interval as the 
second. This was statistically significant. Then unpaired t test was 
performed at each time period to ascertain the pattern and magnitude of 
difference. The incidence of adverse events was compared using Chi-
square test. Data was reported as mean± standard deviation. A p- value of 
< 0.05 was considered statistically significant 
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                                              There was no difference between the groups 
with respect to demographic characteristics or the type and duration of  
surgery. 
 
                                       DEMOGRAPHIC DATA p-
value VARIABLE GABAPENTIN(n=35) PLACEBO(n=33) 
AGE(yr) 35.94 ± 10.52 39.69 ± 10.69 0.768$ 
MALE / 
FEMALE 
7 / 28 6 / 27 0.467$ 
WEIGHT(kg) 52.86 ± 9.23 53.18 ± 7.27 0.71$ 
                                                             
                                       Average age was 35.94± 10.52 years in 
Gabapentin group and 39.69 ± 10.69 years in placebo group with a p 
value of 0.768. There was no statistically significant difference in the 
body weight between the two groups - 52.86 ± 9.23 kg in gabapentin 
group and 53.18 ± 7.27 kg in placebo group ( p=0.71). 
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                                             SURGICAL DATA 
DURATION OF 
SURGERY(min) 
92.29 ± 38.8 88.78 ± 33.52 
SURGICAL METHOD 
Hemithyroidectomy / 
Subtotal thyroidectomy 
/ Total thyroidectomy 
 
10 / 20 / 5 11 / 19 / 3 
 
 
 
                                      Duration of surgery was also similar in both 
groups - 92.29 ± 38.8 minutes in gabapentin group and 88.78 ± 
33.52minutes in placebo group (p=0.118).The distribution of method of 
surgery was also similar in both groups. 
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Post-operative VAS Pain scores 
  Gabapentin(n=35) Placebo(n=33) 
Hours At rest Swallowing At rest Swallowing 
T1 3.6 ±1.9$ 4.57 ±2.1$ 4.24  ±2.2 $   5.3 ±2.2 $ 
T2 3.26 ±1.4* 4.26 ±1.6* 4.21 ±2.1* 4.9 ±2.3* 
T6 3.31 ±1.5* 3.94 ±1.6* 4.63 ±1.5 * 5.5 ±1.7* 
T12 2.74 ±1.7* 3.37 ±1.9* 4.09 ±1.3* 5.18 ±1.5* 
T18 2.2 ±1.4* 2.65 ±1.5* 3.15 ±1.6* 4.12 ±1.8* 
T24 1.69 ±1.4* 2.0 ±1.3* 2.3 ±1.2* 3.24 ±1.7* 
 
$ not significant p value > 0.05 
*statistically significant p value<0.05  
 
                                    The VAS scores at rest and swallowing were 
significantly lesser in Gabapentin group compared with the placebo 
group, except at the 1st hour.  
                                     At first hour even though the VAS score was 
higher in placebo group the difference was not statistically significant. 
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                                  FENTANYL  TOTAL DOSE 
 Total Dose p value 
Gabapentin 141.3 ±59.7 
 
0.0125* 
Placebo 198.9 ±54.4 
 
 
The total fentanyl consumption in Gabapentin group was 141.3mg which 
was significantly less than placebo group 198.9mg  (p=0.0125). 
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                                   POST-OPERATIVE COMPLICATION 
 PONV p 
 
Vertigo p 
 
Respira
tory 
Depres
sion 
p 
 
Ramsay 
Sedation 
Score 
p 
Gaba
penti
n 
11 
(31.43%) 
0.08$ 19 
(54.28
%) 
0.013* 4 
11.43%
0.257$ 3.49±0.57 0.0125* 
Place
bo 
18 
(54.54%) 
7 
(21.21
%) 
2 
6.06% 
2.48±0.61 
 
18 patients (54.54%) in placebo group had post operative nausea or 
vomiting in comparison to 11 patients (31.43%) in gabapentin group 
which was not statistically significant (p=0.08). There was significant 
difference in the incidence of number of patients who had vertigo 
between gabapentin group 19 patients (54.28%) and placebo group 7 
(21.21%) (p=0.013) 
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There was no difference in the incidence of respiratory depression in both 
groups. 4 patients11.43% of gabapentin group and 2 patients 6.06% of 
placebo group had respiratory depression (p=0.257) 
The mean Ramsay Sedation Score was higher in Gabapentin group 
3.49±0.57 compared to placebo group 2.48±0.61. The difference was 
statistically significant with a p value of 0.0125. 
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                                     DISCUSSION 
  
                                        The result of this study shows that pain scores at 
rest and swallowing are significantly less at all times in the first 24 hours 
except in the first hour in the patients who were given oral Gabapentin 
600mg 2 hours before surgery. The total amount of Fentanyl consumed 
were also significantly less in gabapentin group. 
                                           Surgical tissue injury results in neuroplastic 
changes such as metabolic activation and hyperexcitability of spinal 
nociceptive neurons which result in development of pathological pain 
characterized by hyperalgesia and allodynia. Gabapentin decreases 
postoperative pain by its action of inhibiting the neuroplastic changes 
associated with acute tissue injury.3-11 
                                            Gabapentin was also shown in some studies to 
enhance the analgesic effect of opioids  eg. Eckhardt K et al14 
                                           The dose of 600 mg was selected based on the 
study by Pandey CK, Navkar DV11,et al who evaluated the optimal 
preemptive dose of gabapentin for postoperative pain relief after single-
level lumbar diskectomy and its effect on fentanyl consumption during 
49  
the initial 24 hours. They concluded that gabapentin 600 mg is the 
optimal dose for postoperative pain relief. 
                              The pre-emptive administration of gabapentin two 
hours before surgery appears rational so as to attain the peak plasma 
concentration at the time of incision. 
                               Many studies have explored the use of Gabapentin as 
a pre emptive analgesic with mixed results. Most of the studies showed 
decreased pain scores and opioid-sparing effect during the first 24 h after 
a single dose of gabapentin 300-1200 mg, administered 1-2 h 
preoperatively. The opioid sparing effect ranged from 20% to 62%.But 
there was difference between studies with respect to the incidence of side 
effects. 
                      Alparslan Turan, MD*, Beyhan Karamanl21  did a 
randomized, placebo-controlled, double-blind study,on the efficacy and 
safety of gabapentin on pain after abdominal hysterectomy and on 
tramadol consumption. 
                        Similar studies on patients undergoing hysterectomies 
were also done Dierking by G, Duedahl TH et al and Gilron I, Orr E et al. 
                        In  Alparslan Turan study The VAS scores in the sitting 
and supine position at 1, 4, 8, 12, 16, and 20 h were significantly lower in 
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the gabapentin group when compared with the placebo group up to 20 h 
after surgery. The tramadol consumption at 12, 16, 20, and 24 h and total 
tramadol consumption were significantly less in the gabapentin group 
when compared with placebo group. Sedation scores were similar at all 
the measured times. There were no differences between groups in adverse 
effects.  
                   Dierking by G, Duedahl TH et al observed a significant 
inverse association between plasma levels of gabapentin at 2 h 
postoperatively, and morphine usage from 0 to 2 h, and from 0 to 4 h 
postoperatively. No significant differences in pain at rest or during 
mobilization, or in side-effects, were observed between groups.  
                     Gilron I, Orr E et al  also found significantly reduced pain 
scores and opioid sparing effect with gabapentin. Adverse effects were 
similar in all groups except sedation which was more frequent with 
gabapentin. 
 
                       The results of these were similar in terms of the pain scores 
and decreased analgesic requirements to our study. In the former two 
studies side effects were similar in both placebo and gabapentin group. 
Gilron I, Orr E et al  found sedation to be more frequent in gabapentin 
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group. in our study sedation and vertigo were significantly higher in 
patients given gabapentin. 
                    Turan A, Memis D,24  investigated the efficacy and safety of 
gabapentin in patients who underwent rhinoplasty or endoscopic sinus 
surgery patients under monitored anesthesia care. . Postoperative pain 
scores and intraoperative pain scores at 45 and 60 min were significantly 
lower in the gabapentin group. Fentanyl (122 ± 40 µg versus 148 ± 42 µg; 
P < 0.05)) consumption was smaller and the time to first analgesic request 
(18 ± 9 h versus 9 ± 7 h; P < 0.001) was longer in the gabapentin group. 
A more frequent incidence of dizziness was found in the gabapentin 
(versus placebo) group (24% versus 4%, respectively).The findings are 
similar to our study including a higher incidence of dizziness (54%) 
                     Turan A, Karamanlioğlu B,et al also extended their study to 
patients undergoing spine surgeries. they found out that overall, pain 
scores  were significantly lower in the gabapentin group when compared 
with the placebo group. Total morphine consumption in the gabapentin 
group was 16.3 +/- 8.9 mg (mean +/- SD) versus 42.8 +/- 10.9 mg in the 
placebo patients. The incidence of vomiting and urinary retention was 
significantly (P < 0.05) higher in the placebo group, but there was no 
difference in incidence of other adverse effects between the groups. The 
findings are similar to our study except that there was no statistically 
significant difference in incidence of vomiting in our study.34.43% in 
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gabapentin and 54.545 in placebo(p=0.08).None of our patients also had 
urinary retention. 
.            28Dirks J, Fredensborg BB did similar study in patients 
undergoing mastectomies.Gabapentin reduced total morphine 
consumption from a median of 29 (interquartile range, 21-33) to 15 (10-
19) mg (P< 0.0001). Pain during movement was reduced from 41 (31-59) 
to 22 (10-38) mm at 2 h postoperatively (P < 0.0001) and from 31 (12-40) 
to 9 (3-34) mm at 4 h postoperatively (P = 0.018). No significant 
differences between groups were observed with regard to pain at rest or 
side effects.Al-Mujadi H, A-Refai 19AR studied gabapentin in 
thyroidectomies.Overall, pain scores at rest and during swallowing in the 
gabapentin group were significantly lower when compared with the 
placebo group. Total postoperative morphine consumption in the 
gabapentin group was 15.2 +/- 7.6 mg (mean +/- SD) vs 29.5 +/- 9.9 mg 
in the placebo group (P < 0.001). No significant differences in side effects 
were observed between groups. 
                          In our study the VAS scores measured at 1st hour after 
surgery were higher in gabapentin group compared to the placebo but the 
difference was not statistically significant. This higher VAS scores in the 
first hour compared to other times in the placebo group could be 
attributed to the residual analgesic effect of fentanyl given intra 
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operatively and also to the residual effect of anesthetic which could have 
influenced the measurement of VAS scoring in both groups. Fassoulaki 
A, Stamatakis E studied the effect of perioperative gabapentin 
administration on pain following abdominal hysterectomies. They 
conclude that Gabapentin attenuates late but not acute pain after 
abdominal hysterectomy. 
             Two systematic reviews by Mathiesen O, Møiniche S, Dahl JB 
and   Tiippana EM, Hamunen K, Kontinen VK, showed a significant 
reduction in morphine. Tiippana EM, Hamunen K, Kontinen VK,  also 
said that The most common adverse effects of the gabapentin were 
sedation and dizziness32,33 
               Despite differences in surgical techniques most of the studies showed 
significant effect of gabapentin on post operative analgesic requirements. Our results 
are consistent with these studies.Although there was a higher incidence of sedation 
and dizziness in gabapentin group, it was well tolerated by the patients and none of 
them required treatment.Patients are understandably anxious during the perioperative 
period and this can be a significant problem in some. The higher incidence of sedation 
with gabapentin in our study could be an added advantage of Gabapentin. Its 
anxiolytic properties are described by studies by Chouinard G et al and de-Paris F, 
Sant'Anna MK, et al .29 30 
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SUMMARY 
 
                                 Surgical tissue injury is known to produce 
neuroplastic changes leading to spinal sensitization and the expression of 
stimulus-evoked hyperalgesia and allodynia. Anticonvulsants, which 
were long being used to treat neuropathic pain is found to inhibit these 
neuroplastic changes from occurring. Among them recent studies have 
focused the role of gabapentin in post operative pain relief. 
                              This is a prospective, randomized, placebo controlled 
study to find out if  preemptive administration of 600mg oral gabapentin 
2 hours before thyroid  surgery reduces pain and analgesic requirement in 
the post operative period. 
                              Data from 35 patients in gabapentin group and 33 
patients in placebo group were analyzed. The results showed significantly 
lower pain scores and analgesic requirements in gabapentin group. There 
was high incidence of dizziness and higher sedation in patients who had 
gabapentin. 
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CONCLUSION 
                       Our study demonstrated that a 600 mg single pre-
emptive oral dose of Gabapentin significantly reduces post 
operative pain and analgesic requirement following thyroid 
surgeries. There was an increased incidence of sedation and 
vertigo in patients given gabapentin, but these were well 
tolerated by the patients. Thus Gabapentin can be considered as 
an useful adjunctive to opiods in the treatment of post-operative 
pain. 
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